Big news in this new Hot Topics podcast as we discuss very positive data on the role of inhaled budesonide for early mild COVID in community-based patients - the STOIC trial may radically change our management of COVID but why hasn't this been a huge story and should we wait to change our practice?

Also, we look at a BMJ paper examining the risk of catching and dying from COVID if you are an adult with children at home, a Lancet paper looking at only 3 days of antibiotics for pneumonia and more data on semaglutide and it's role in weight loss and improvement in non-alcoholic steatohepatitis.

References:
STOIC website and pre-print
BMJ COVID and kids cohort study
Lancet Pneumonia trial
Lancet Semaglutide and weight loss in T2DM
NEJM Semaglutide and NASH

www.nbmedical.com/podcast